Pharma Market Access Insights - from Petauri Evidence

• The Evolving NHS – An ICS Chief Pharmacist’s Perspective

  Send us a textWhat does the evolving NHS landscape look like through the eyes of a Chief Pharmacist, and how are integrated care system (ICS) pharmacy teams responding?In this Petauri Evidence NHS Whispers session, we put your questions to Yousaf Ahmad (Chief Pharmacist and Director of Medicines Optimisation, Frimley ICS), as he shares how he and his colleagues are responding to the changing NHS environment. From system pressures and financial constraints to prescribing priorities and service redesign, Yousaf explored how ICS pharmacy teams are adapting, and what this means for industry partners.This episode was first broadcast as live webinar on: Friday 24th October 2025.Learn more about this episode at https://petauri.com/insights/evolving-nhs-ics-chief-pharmacists-perspective/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  31:25

  --------

  31:25
• First to Market: Unlocking Switzerland’s Pharma Potential

  Send us a textWhat makes Switzerland a compelling first-launch market for Pharma? How does its healthcare system compare to other European countries? What do manufacturers need to know about reimbursement, pricing, and evidence requirements? How might the evolving Joint Clinical Assessment (JCA) landscape influence launch sequencing?This episode explores Switzerland’s potential as an early launch market.In this session, Louise Maddison (Senior Consultant – Global Pricing and Market Access, Petauri Evidence) interviewed Dr Elisabeth Brock (Independent expert in market access in Switzerland), who has extensive experience in Swiss healthcare, including regulatory and payer engagement, dossier preparation for the Swiss Specialities List (SL), and strategic launch planning.Together, we explored what global market access teams need to know about launching in Switzerland – from regulatory routes and pricing frameworks to the nuances of payer expectations and evidence generation.We discussed:- What makes Switzerland attractive as a first-launch market - Key differences between Swiss and European Union (EU) market access pathways - How to prepare for inclusion on the SL and what “economically efficient pricing” really means - The role of cantonal (state) variation and decentralised healthcare in shaping access - How Swiss decisions may be influenced by the EU’s JCA - What global teams can learn from Swiss strategy to inform broader launch planningThis episode was first broadcast as a live webinar on Thursday 16th October 2025Learn more at  https://petauri.com/insights/market-access-switzerland/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  44:31

  --------

  44:31
• Q&A Webinar: The Evolving NHS Landscape in England – From Policy to Practice

  Send us a textIn this NHS Whispers live Q&A webinar, Katie Mulholland (Senior Consultant, UK Market Access, Petauri Evidence) speaks to: - Sarah Everest Ford (Programme Director, Health and Care Partnership) - Patrick McGee (Deputy Programme Director for Pathology, Lancashire & South Cumbria) - Prof. Phil Richardson (Former Dorset ICS System Commissioning Director; now Chief Innovation Officer, Petauri Evidence)Together, they explore the implications of changing NHS structure and policy, and what this means for your market access, stakeholder engagement, and product innovation strategies.This episode was first broadcast as a live webinar on 19th September 2025. Some to the topics discussed may evolve over time. This session was shaped by your questions. Key themes included: - Evolving NHS structures, policies, and practices – and what this means for industry - Strategic commissioning: where will it happen, and who will lead it?- The 10 Year Plan and its implications for innovation and access - How industry can adapt to new engagement models and financial constraints - What the shift to integrated neighbourhoods means for product rollout and service designLearn more at: https://petauri.com/insights/evolving-nhs-landscape-policy-to-practice/For support with navigating the evolving NHS and launching new medicines and products in England, please email [email protected]. Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  1:00:10

  --------

  1:00:10
• Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

  Send us a textUncover the forces driving change in global pricing and accessIn this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this episode, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry.Ben Spurr (Head of Partnerships, Petauri Evidence) hosts the panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies.This episode was first broadcast as a live webinar. Learn more at: https://petauri.com/insights/webinar-global-pricing-market-access-strategies/Discover our global pricing and market access services at: https://petauri.com/gpma/ To explore your pricing and market access strategy with our experts or to put your question to the panel, email [email protected] to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  52:41

  --------

  52:41
• Transforming Global Market Access: Smarter Resource Management with Local Affiliates

  Send us a textDiscover a smarter way to manage and share market access resources with local affiliatesAre your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed how a centralised platform can streamline resource sharing, ensure access to nationally-relevant evidence, and put the resources your local affiliates need right at their fingertips. The webinar features a conversation with Tim Styche (Market Access & Health Outcomes Director, Smith+Nephew), who shares how his team has solved this challenge with our Global Value Platform.Learn more at: https://petauri.com/insights/transforming-global-market-access-smarter-resource-management-with-local-affiliates-a-live-webinar/To discuss your needs or arrange a full demo of the platform email [email protected]  Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  33:52

  --------

  33:52

Mais podcasts de Negócios

Podcasts em tendência em Negócios

Sobre Pharma Market Access Insights - from Petauri Evidence